Accendra Health Inc (ACH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -362,686 | -41,301 | 1,915,120 | 1,577,711 | 330,302 |
| Depreciation Amortization | 571,887 | 287,377 | 1,562,036 | 1,320,946 | 1,287,910 |
| Income taxes - deferred | -26,115 | -23,648 | N/A | N/A | N/A |
| Accounts receivable | -94,550 | 165,167 | -192,650 | -200,718 | -592,788 |
| Accounts payable and accrued liabilities | 65,187 | 30,997 | 683,342 | 204,365 | 461,225 |
| Other Working Capital | -15,194 | 520,825 | -238,070 | 352,462 | -162,376 |
| Other Operating Activity | 22,966 | -198,707 | 292,894 | 1,175,196 | 956,394 |
| Operating Cash Flow | $161,495 | $740,710 | $4,022,673 | $4,429,963 | $2,280,666 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 2,016,508 | N/A |
| PPE Investments | -107,439 | -119,296 | -633,364 | -161,335 | -537,107 |
| Net Acquisitions | N/A | N/A | 13,701 | 11,289 | 7,142 |
| Purchase Of Investment | N/A | N/A | -2,222,641 | -53,510 | -1,077,671 |
| Sale Of Investment | N/A | N/A | 2,185,246 | 7,908 | 1,717,668 |
| Purchase Sale Intangibles | -17,297 | -17,022 | -42,882 | -10,236 | 44,879 |
| Other Investing Activity | -9,094 | -17,958 | 161,453 | -1,937,657 | 186,188 |
| Investing Cash Flow | $-116,533 | $-137,254 | $-495,605 | $-116,797 | $296,220 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 4,583,113 | 8,534,587 | 11,022,440 |
| Debt Issued | 2,101,600 | 476,000 | 297,222 | N/A | 153,257 |
| Debt Repayment | -2,345,797 | -892,693 | -368,762 | -845,220 | -306,513 |
| Common Stock Issued | N/A | N/A | 58,674 | N/A | N/A |
| Dividend Paid | N/A | N/A | -364,356 | -72,301 | -54,611 |
| Other Financing Activity | -23,406 | -637 | -8,125,996 | -10,516,710 | -13,231,954 |
| Financing Cash Flow | $-267,603 | $-417,330 | $-3,920,105 | $-2,899,644 | $-2,417,381 |
| Exchange Rate Effect | -901 | 613 | -22,629 | 11,599 | -13,548 |
| Beginning Cash Position | 272,924 | 86,185 | 2,853,856 | 1,376,443 | 1,192,161 |
| End Cash Position | 49,382 | 272,924 | 2,438,190 | 2,801,564 | 1,338,118 |
| Net Cash Flow | $-223,542 | $186,739 | $-415,666 | $1,425,121 | $145,957 |
| Free Cash Flow | |||||
| Operating Cash Flow | 161,495 | 740,710 | 4,022,673 | 4,429,963 | 2,280,666 |
| Capital Expenditure | -210,865 | -190,870 | -640,305 | -320,019 | -772,245 |
| Free Cash Flow | -49,370 | 549,840 | 3,382,368 | 4,109,944 | 1,508,421 |